A model-based economic analysis of the CFHealthHub intervention to support adherence to inhaled medications for people with cystic fibrosis in the UK.
Paul TappendenAline Navega BizMónica Hernández AlavaAlessandro SassoLaura SuttonKate EnnisRachel ElliottMartin WildmanPublished in: International journal of technology assessment in health care (2023)
The CFHH intervention is expected to dominate usual care, irrespective of the duration over which the intervention is delivered. The modeled benefits and cost savings are smaller than initially expected and are sensitive to relative treatment effects on lung function.